Role of Il-17A in murine models of COPD airway disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 312, Issue 1, 2016, Pages L122-L130

  Yanagisawa, Haruhiko ^a   Hashimoto, Mitsuo ^a   Minagawa, Shunsuke ^a   Takasaka, Naoki ^a   Ma, Royce ^a   Moermans, Catherine ^a   Ito, Saburo ^a   Araya, Jun ^b   Budelsky, Alison ^c   Goodsell, Amanda ^a   Baron, Jody L ^a   Nishimura, Stephen L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AMGEN INC   (United States)

Author keywords

Airway; Cigarette smoke; Fibrosis; Inflammation; Interleukin 17

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; IL17R PROTEIN, MOUSE; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROSIS; IMMUNOPATHOGENESIS; LYMPHOID CELL; MOUSE; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RESPIRATORY TRACT INFLAMMATION; TH17 CELL; ADENOVIRIDAE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; LUNG FIBROSIS; METABOLISM; PATHOLOGY; PNEUMONIA; SERODIAGNOSIS; SMOKING;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; INTERLEUKIN-17; INTERLEUKIN-1BETA; MICE, INBRED C57BL; NEUTRALIZATION TESTS; PNEUMONIA; POLY I-C; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; RECEPTORS, INTERLEUKIN-17; SMOKING;

EID: 85009469627     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00301.2016     Document Type: Article

References (69)

1. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30: 556-565, 2009. doi:10.1016/j.immuni.2009.02.005.
2. Anderton MJ, Mellor HR, Bell A, Sadler C, Pass M, Powell S, Steele SJ, Roberts RR, Heier A. Induction of heart valve lesions by smallmolecule ALK5 inhibitors. Toxicol Pathol 39: 916-924, 2011. doi:10.1177/0192623311416259.
3. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Filì L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S. Phenotypic and functional features of human Th17 cells. J Exp Med 204: 1849-1861, 2007. doi:10.1084/jem.20070663.
4. Araya J, Cambier S, Markovics JA, Wolters P, Jablons D, Hill A, Finkbeiner W, Jones K, Broaddus VC, Sheppard D, Barzcak A, Xiao Y, Erle DJ, Nishimura SL. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest 117: 3551-3562, 2007. doi:10.1172/JCI32526.
5. Araya J, Cambier S, Morris A, Finkbeiner W, Nishimura SL. Integrinmediated transforming growth factor-beta activation regulates homeosta-sis of the pulmonary epithelial-mesenchymal trophic unit. Am J Pathol 169: 405-415, 2006. doi:10.2353/ajpath.2006.060049.
6. Araya J, Nishimura SL. Fibrogenic reactions in lung disease. Annu Rev Pathol 5: 77-98, 2010. doi:10.1146/annurev.pathol.4.110807.092217.
7. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238, 2006. doi:10.1038/nature04753.
8. Botelho FM, Bauer CM, Finch D, Nikota JK, Zavitz CC, Kelly A, Lambert KN, Piper S, Foster ML, Goldring JJ, Wedzicha JA, Bassett J, Bramson J, Iwakura Y, Sleeman M, Kolbeck R, Coyle AJ, Humbles AA, Stämpfli MR. IL-1β/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One 6: e28457, 2011. doi:10.1371/journal.pone.0028457.
9. Bozinovski S, Seow HJ, Chan SP, Anthony D, McQualter J, Hansen M, Jenkins BJ, Anderson GP, Vlahos R. Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette-smokeinduced lung inflammation in mice. Clin Sci (Lond) 129: 785-796, 2015. doi:10.1042/CS20140703.
10. Brand OJ, Somanath S, Moermans C, Yanagisawa H, Hashimoto M, Cambier S, Markovics J, Bondesson AJ, Hill A, Jablons D, Wolters P, Lou J, Marks JD, Baron JL, Nishimura SL. Transforming growth factor-β and interleukin-1β signaling pathways converge on the chemokine CCL20 promoter. J Biol Chem 290: 14717-14728, 2015. doi:10.1074/jbc.M114.630368.
11. Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, Kreindler JL, Keyser MR, Shapiro SD, Houghton AM, Kolls JK, Zheng M. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One 6: e20333, 2011. doi:10.1371/journal.pone.0020333.
12. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, Dong C. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587, 2009. doi:10.1016/j.immuni.2009.02.007.
13. Churg A, Zhou S, Wang X, Wang R, Wright JL. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 40: 482-490, 2009. doi:10.1165/rcmb.2008-0038OC.
14. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, McCormick M, Woods J, May R, Sleeman MA, Anderson IK, Brightling CE. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 138: 1140-1147, 2010. doi:10.1378/chest.09-3058.
15. Doz E, Noulin N, Boichot E, Guénon I, Fick L, Le Bert M, Lagente V, Ryffel B, Schnyder B, Quesniaux VF, Couillin I. Cigarette smokeinduced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 180: 1169-1178, 2008. doi:10.4049/jimmunol.180.2.1169.
16. Fjellbirkeland L, Cambier S, Broaddus VC, Hill A, Brunetta P, Dolganov G, Jablons D, Nishimura SL. Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue. Am J Pathol 163: 533-542, 2003. doi:10.1016/S0002-9440(10)63681-4.
17. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9: 556-567, 2009. doi:10.1038/nri2586.
18. Ganter MT, Roux J, Miyazawa B, Howard M, Frank JA, Su G, Sheppard D, Violette SM, Weinreb PH, Horan GS, Matthay MA, Pittet JF. Interleukin-1β causes acute lung injury via αvβ5 and αvβ6 integrin-dependent mechanisms. Circ Res 102: 804-812, 2008. doi:10.1161/CIRCRESAHA.107.161067.
19. Gasse P, Riteau N, Vacher R, Michel ML, Fautrel A, di Padova F, Fick L, Charron S, Lagente V, Eberl G, Le Bert M, Quesniaux VF, Huaux F, Leite-de-Moraes M, Ryffel B, Couillin I. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS One 6: e23185, 2011. doi:10.1371/journal.pone.0023185.
20. Geraghty P, Dabo AJ, D’Armiento J. TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem 286: 30211-30218, 2011. doi:10.1074/jbc.M111.238824.
21. Gessner C, Scheibe R, Wötzel M, Hammerschmidt S, Kuhn H, Engelmann L, Hoheisel G, Gillissen A, Sack U, Wirtz H. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med 99: 1229-1240, 2005. doi:10.1016/j.rmed.2005.02.041.
22. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132, 2005. doi:10.1038/ni1254.
23. Hashimoto M, Yanagisawa H, Minagawa S, Sen D, Goodsell A, Ma R, Moermans C, McKnelly KJ, Baron JL, Krummel MF, Nishimura SL. A critical role for dendritic cells in the evolution of IL-1β-mediated murine airway disease. J Immunol 194: 3962-3969, 2015. doi:10.4049/jimmunol.1403043.
24. Hashimoto M, Yanagisawa H, Minagawa S, Sen D, Ma R, Murray LA, Tsui P, Lou J, Marks JD, Baron JL, Krummel MF, Nishimura SL. TGF-β-dependent dendritic cell chemokinesis in murine models of airway disease. J Immunol 195: 1182-1190, 2015. doi:10.4049/jimmunol.1500348.
25. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653, 2004. doi:10.1056/NEJMoa032158.
26. Homer RJ, Elias JA, Lee CG, Herzog E. Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med 135: 780-788, 2011.
27. Huang Q, Han J, Fan J, Duan L, Guo M, Lv Z, Hu G, Chen L, Wu F, Tao X, Xu J, Jin Y. IL-17 induces EMT via Stat3 in lung adenocarcinoma. Am J Cancer Res 6: 440-451, 2016.
28. Irvin CG, Bates JH. Measuring the lung function in the mouse: the challenge of size. Respir Res 4: 1, 2003. doi:10.1186/rr199.
29. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352: 1967-1976, 2005. doi:10.1056/NEJMoa041892.
30. Ito S, Araya J, Kurita Y, Kobayashi K, Takasaka N, Yoshida M, Hara H, Minagawa S, Wakui H, Fujii S, Kojima J, Shimizu K, Numata T, Kawaishi M, Odaka M, Morikawa T, Harada T, Nishimura SL, Kaneko Y, Nakayama K, Kuwano K. PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis. Autophagy 11: 547-559, 2015. doi:10.1080/15548627.2015.1017190.
31. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 116: 1218-1222, 2006. doi:10.1172/JCI28508.
32. Jin W, Dong C. IL-17 cytokines in immunity and inflammation. Emerg Microbes Infect 2: e60, 2013. doi:10.1038/emi.2013.58.
33. Jin Y, Wan Y, Chen G, Chen L, Zhang MQ, Deng L, Zhang JC, Xiong XZ, Xin JB. Treg/IL-17 ratio and Treg differentiation in patients with COPD. PLoS One 9: e111044, 2014. doi:10.1371/journal.pone.0111044.
34. Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, Elias JA. Cigarette smoke selectively enhances viral PAMP-and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 118: 2771-2784, 2008. doi:10.1172/JCI32709.
35. Kim HY, Lee HJ, Chang YJ, Pichavant M, Shore SA, Fitzgerald KA, Iwakura Y, Israel E, Bolger K, Faul J, DeKruyff RH, Umetsu DT. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 20: 54-61, 2014. doi:10.1038/nm.3423.
36. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370: 2083-2092, 2014. doi:10.1056/NEJMoa1402582.
37. Kitamura H, Cambier S, Somanath S, Barker T, Minagawa S, Markovics J, Goodsell A, Publicover J, Reichardt L, Jablons D, Wolters P, Hill A, Marks JD, Lou J, Pittet JF, Gauldie J, Baron JL, Nishimura SL. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β. J Clin Invest 121: 2863-2875, 2011. doi:10.1172/JCI45589.
38. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107: 1529-1536, 2001. doi:10.1172/JCI12568.
39. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 21: 467-476, 2004. doi:10.1016/j.immuni.2004.08.018.
40. Kudo M, Melton AC, Chen C, Engler MB, Huang KE, Ren X, Wang Y, Bernstein X, Li JT, Atabai K, Huang X, Sheppard D. IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice andenhances mouse and human airway smooth muscle contraction. Nat Med 18: 547-554, 2012. doi:10.1038/nm.2684.
41. Lendermon EA, Dodd-o JM, Coon TA, Miller HL, Ganguly S, Popescu I, O’Donnell CP, Cardenes N, Levine M, Rojas M, Weathington NM, Zhao J, Zhao Y, McDyer JF. CD8(+)IL-17(+) T cells mediate neutrophilic airway obliteration in T-bet-deficient mouse lung allograft recipients. Am J Respir Cell Mol Biol 52: 622-633, 2015. doi:10.1165/rcmb.2014-0059OC.
42. Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol 5: 483-492, 2013. doi:10.2147/CLEP.S54815.
43. Lucattelli M, Cicko S, Müller T, Lommatzsch M, De Cunto G, Cardini S, Sundas W, Grimm M, Zeiser R, Dürk T, Zissel G, Sorichter S, Ferrari D, Di Virgilio F, Virchow JC, Lungarella G, Idzko M. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am J Respir Cell Mol Biol 44: 423-429, 2011. doi:10.1165/rcmb.2010-0038OC.
44. Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma YG, Wang XX, Liu HZ, Sun W, Hu ZW. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and-independent mechanisms. J Immunol 187: 3003-3014, 2011. doi:10.4049/jimmunol.1004081.
45. Minagawa S, Lou J, Seed RI, Cormier A, Wu S, Cheng Y, Murray L, Tsui P, Connor J, Herbst R, Govaerts C, Barker T, Cambier S, Yanagisawa H, Goodsell A, Hashimoto M, Brand OJ, Cheng R, Ma R, McKnelly KJ, Wen W, Hill A, Jablons D, Wolters P, Kitamura H, Araya J, Barczak AJ, Erle DJ, Reichardt LF, Marks JD, Baron JL, Nishimura SL. Selective targeting of TGF-β activation to treat fibroinflammatory airway disease. Sci Transl Med 6: 241ra79, 2014. doi:10.1126/scitranslmed.3008074.
46. Miniño AM, Xu J, Kochanek KD. Deaths: preliminary data for 2008. Natl Vital Stat Rep 59: 1-52, 2010.
47. Molyneaux PL, Maher TM. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. Eur Respir Rev 22: 376-381, 2013. doi:10.1183/09059180.00000713.
48. Nishimura SL. Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol 175: 1362-1370, 2009. doi:10.2353/ajpath.2009.090393.
49. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173: 1114-1121, 2006. doi:10.1164/rccm.200506-859OC.
50. Phillips B, Veljkovic E, Peck MJ, Buettner A, Elamin A, Guedj E, Vuillaume G, Ivanov NV, Martin F, Boué S, Schlage WK, Schneider T, Titz B, Talikka M, Vanscheeuwijck P, Hoeng J, Peitsch MC. A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. Food Chem Toxicol 80: 328-345, 2015. doi:10.1016/j.fct.2015.03.009.
51. Postma DS, Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 3: 434-439, 2006. doi:10.1513/pats.200601-006AW.
52. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370: 2071-2082, 2014. doi:10.1056/NEJMoa1402584.
53. Saika S, Kono-Saika S, Tanaka T, Yamanaka O, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Yoo J, Flanders KC, Roberts AB. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest 84: 1245-1258, 2004. doi:10.1038/labinvest.3700156.
54. Shan M, Cheng HF, Song LZ, Roberts L, Green L, Hacken-Bitar J, Huh J, Bakaeen F, Coxson HO, Storness-Bliss C, Ramchandani M, Lee SH, Corry DB, Kheradmand F. Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med 1: 4ra10, 2009. doi:10.1126/scitranlsmed.3000154.
55. Sharma AK, LaPar DJ, Zhao Y, Li L, Lau CL, Kron IL, Iwakura Y, Okusa MD, Laubach VE. Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med 183: 1539-1549, 2011. doi:10.1164/rccm.201007-1173OC.
56. Sichelstiel A, Yadava K, Trompette A, Salami O, Iwakura Y, Nicod LP, Marsland BJ. Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation. PLoS One 9: e98440, 2014. doi:10.1371/journal.pone.0098440.
57. Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 6: 524-526, 2009. doi:10.1513/pats.200904-016DS.
58. Tan Z, Qian X, Jiang R, Liu Q, Wang Y, Chen C, Wang X, Ryffel B, Sun B. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 191: 1835-1844, 2013. doi:10.4049/jimmunol.1203013.
59. Vanoirbeek JA, Rinaldi M, De Vooght V, Haenen S, Bobic S, Gayan-Ramirez G, Hoet PH, Verbeken E, Decramer M, Nemery B, Janssens W. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 42: 96-104, 2010. doi:10.1165/rcmb.2008-0487OC.
60. Vargas-Rojas MI, Ramírez-Venegas A, Limón-Camacho L, Ochoa L, Hernández-Zenteno R, Sansores RH. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 105: 1648-1654, 2011. doi:10.1016/j.rmed.2011.05.017.
61. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189, 2006. doi:10.1016/j.immuni.2006.01.001.
62. Vitsky A, Waire J, Pawliuk R, Bond A, Matthews D, Lacasse E, Hawes ML, Nelson C, Richards S, Piepenhagen PA, Garman RD, Andrews L, Thurberg BL, Lonning S, Ledbetter S, Ruzek MC. Homeostatic role of transforming growth factor-beta in the oral cavity and esophagus of mice and its expression by mast cells in these tissues. Am J Pathol 174: 2137-2149, 2009. doi:10.2353/ajpath.2009.080723.
63. Weaver CT, Elson CO, Fouser LA, Kolls JK. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 8: 477-512, 2013. doi:10.1146/annurev-pathol-011110-130318.
64. Werner JL, Gessner MA, Lilly LM, Nelson MP, Metz AE, Horn D, Dunaway CW, Deshane J, Chaplin DD, Weaver CT, Brown GD, Steele C. Neutrophils produce interleukin 17A (IL-17A) in a dectin-1-and IL-23-dependent manner during invasive fungal infection. Infect Immun 79: 3966-3977, 2011. doi:10.1128/IAI.05493-11.
65. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, Cheever AW, Wynn TA. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207: 535-552, 2010. doi:10.1084/jem.20092121.
66. Witowski J, Ksiazek K, Jörres A. Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 61: 567-579, 2004. doi:10.1007/s00018-003-3228-z.
67. Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9: 157-179, 2014. doi:10.1146/annurevpathol-012513-104706.
68. Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP, Whitters MJ, Tomkinson KN, Fitz LJ, Wolfman NM, Collins M, Dunussi-Joannopoulos K, Chatterjee-Kishore M, Carreno BM. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 181: 2799-2805, 2008. doi:10.4049/jimmunol.181.4.2799.
69. Zhang L, Cheng Z, Liu W, Wu K. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. COPD 10: 459-465, 2013. doi:10.3109/15412555.2013.770456.